Literature DB >> 21949050

Dissociation of diabetes and obesity in mice lacking orphan nuclear receptor small heterodimer partner.

Young Joo Park1, Seong Chul Kim2, Jeehee Kim2, Sayeepriyadarshini Anakk3, Jae Man Lee3, Hsiu-Ting Tseng3, Vijay Yechoor4, Junchol Park5, June-Seek Choi5, Hak Chul Jang6, Ki-Up Lee7, Colleen M Novak8, David D Moore9, Yoon Kwang Lee10.   

Abstract

Mixed background SHP(-/-) mice are resistant to diet-induced obesity due to increased energy expenditure caused by enhanced PGC-1α expression in brown adipocytes. However, congenic SHP(-/-) mice on the C57BL/6 background showed normal expression of PGC-1α and other genes involved in brown adipose tissue thermogenesis. Thus, we reinvestigated the impact of small heterodimer partner (SHP) deletion on diet-induced obesity and insulin resistance using congenic SHP(-/-) mice. Compared with their C57BL/6 wild-type counterparts, SHP(-/-) mice subjected to a 6 month challenge with a Western diet (WestD) were leaner but more glucose intolerant, showed hepatic insulin resistance despite decreased triglyceride accumulation and increased β-oxidation, exhibited alterations in peripheral tissue uptake of dietary lipids, maintained a higher respiratory quotient, which did not decrease even after WestD feeding, and displayed islet dysfunction. Hepatic mRNA expression analysis revealed that many genes expressed higher in SHP(-/-) mice fed WestD were direct peroxisome proliferator-activated receptor alpha (PPARα) targets. Indeed, transient transfection and chromatin immunoprecipitation verified that SHP strongly repressed PPARα-mediated transactivation. SHP is a pivotal metabolic sensor controlling lipid homeostasis in response to an energy-laden diet through regulating PPARα-mediated transactivation. The resultant hepatic fatty acid oxidation enhancement and dietary fat redistribution protect the mice from diet-induced obesity and hepatic steatosis but accelerate development of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21949050      PMCID: PMC3220290          DOI: 10.1194/jlr.M016048

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

Review 1.  Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.

Authors:  George A Bray; Tracy Bellanger
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation.

Authors:  Yoon-Kwang Lee; Yun-Hee Choi; Steven Chua; Young Joo Park; David D Moore
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

3.  Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle.

Authors:  Tonya L Martin; Thierry Alquier; Kenji Asakura; Noboru Furukawa; Frederic Preitner; Barbara B Kahn
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

4.  Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339.

Authors:  John S Millar; Debra A Cromley; Mary G McCoy; Daniel J Rader; Jeffrey T Billheimer
Journal:  J Lipid Res       Date:  2005-07-01       Impact factor: 5.922

5.  The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes.

Authors:  Li Wang; Jun Liu; Pradip Saha; Jiansheng Huang; Lawrence Chan; Bruce Spiegelman; David D Moore
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

6.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

Authors:  Takeshi Inagaki; Mihwa Choi; Antonio Moschetta; Li Peng; Carolyn L Cummins; Jeffrey G McDonald; Guizhen Luo; Stacey A Jones; Bryan Goodwin; James A Richardson; Robert D Gerard; Joyce J Repa; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

7.  Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis.

Authors:  Jianqiang Mao; Francesco J DeMayo; Huiguang Li; Lutfi Abu-Elheiga; Ziwei Gu; Tattym E Shaikenov; Parichher Kordari; Subrahmanyam S Chirala; William C Heird; Salih J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

8.  Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.

Authors:  Holger Doege; Rebecca A Baillie; Angelica M Ortegon; Bernice Tsang; Qiwei Wu; Sandhya Punreddy; David Hirsch; Nicki Watson; Ruth E Gimeno; Andreas Stahl
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

9.  FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity.

Authors:  Qiwei Wu; Angelica M Ortegon; Bernice Tsang; Holger Doege; Kenneth R Feingold; Andreas Stahl
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

10.  Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.

Authors:  Angie L Bookout; Yangsik Jeong; Michael Downes; Ruth T Yu; Ronald M Evans; David J Mangelsdorf
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

View more
  27 in total

1.  LRH-1-dependent glucose sensing determines intermediary metabolism in liver.

Authors:  Maaike H Oosterveer; Chikage Mataki; Hiroyasu Yamamoto; Taoufiq Harach; Norman Moullan; Theo H van Dijk; Eduard Ayuso; Fatima Bosch; Catherine Postic; Albert K Groen; Johan Auwerx; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

2.  Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner.

Authors:  Xian Pan; Yoon-Kwang Lee; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2015-04-29       Impact factor: 3.922

3.  Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.

Authors:  Yong Deuk Kim; Tiangang Li; Seung-Won Ahn; Don-Kyu Kim; Ji-Min Lee; Seung-Lark Hwang; Yong-Hoon Kim; Chul-Ho Lee; In-Kyu Lee; John Y L Chiang; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2012-09-12       Impact factor: 5.157

4.  Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.

Authors:  Sunmi Seok; Deepthi Kanamaluru; Zhen Xiao; Daniel Ryerson; Sung-E Choi; Kelly Suino-Powell; H Eric Xu; Timothy D Veenstra; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

5.  Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  An Zou; Nancy Magee; Fengyan Deng; Sarah Lehn; Cuncong Zhong; Yuxia Zhang
Journal:  J Biol Chem       Date:  2018-04-17       Impact factor: 5.157

6.  Enhanced ethanol catabolism in orphan nuclear receptor SHP-null mice.

Authors:  Jung Eun Park; Mikang Lee; Ryan Mifflin; Yoon Kwang Lee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-11       Impact factor: 4.052

7.  Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice.

Authors:  Oludemilade Akinrotimi; Ryan Riessen; Philip VanDuyne; Jung Eun Park; Yoon Kwang Lee; Lee-Jun Wong; Ann M Zavacki; Kristina Schoonjans; Sayeepriyadarshini Anakk
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

8.  Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.

Authors:  Kang Ho Kim; Sungwoo Choi; Ying Zhou; Eun Young Kim; Jae Man Lee; Pradip K Saha; Sayeepriyadarshini Anakk; David D Moore
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

9.  Beyond Farnesoid X receptor to target new therapies for NAFLD.

Authors:  Xiaoying Liu; Richard M Green
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

10.  All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade.

Authors:  Seong Chul Kim; Chun-Ki Kim; David Axe; Aaron Cook; Mikang Lee; Tiangang Li; Nicole Smallwood; John Y L Chiang; James P Hardwick; David D Moore; Yoon Kwang Lee
Journal:  Hepatology       Date:  2014-03-26       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.